We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cochlear Limited | ASX:COH | Australian Stock Exchange | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.49 | -0.46% | 320.74 | 317.98 | 323.00 | 321.19 | 317.10 | 318.85 | 110,194 | 09:50:00 |
From May 2019 to May 2024
Swiss hearing aid maker Sonova Holdings AG (SOON.VX) will maintain sufficient financial flexibility to pursue further growth initiatives after announcing plans to buy U.S.-based cochlear implant systems maker Advanced Bionics Corporation, Chief Executive Valentin Chapero said Monday.
Earlier Monday, Sonova said it plans to buy the U.S.-based cochlear implant systems maker for $489 million, which was widely welcomed by the market.
The deal, which costs Sonova a total of 510 million Swiss francs ($505.9 million), is subject to regulatory approval.
Sonova will report first half figures for its 2010 fiscal year on Tuesday.
Company Web Site: http://www.sonova.com
-By Julia Mengewein, Dow Jones Newswires; +41 43 443 80 45; julia.mengewein@dowjones.com
1 Year Cochlear Chart |
1 Month Cochlear Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
